BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1493543)

  • 1. Thymopoietin, a thymic polypeptide, prevents nicotinic agonist-induced morphological changes in neonatal muscle cells in culture.
    Quik M; Philie J; Goldstein G
    Brain Res; 1992 Dec; 599(1):117-28. PubMed ID: 1493543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymopoietin, a potent antagonist at nicotinic receptors in C2 muscle cell cultures.
    Quik M; el-Bizri H; Audhya T; Goldstein G
    Mol Pharmacol; 1991 Mar; 39(3):324-31. PubMed ID: 2005877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymopoietin interacts at the alpha-bungarotoxin site of and induces process formation in PC12 pheochromocytoma cells.
    Quik M; Cohen R; Audhya T; Goldstein G
    Neuroscience; 1990; 39(1):139-50. PubMed ID: 2089274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymopoietin, a thymic polypeptide, regulates nicotinic alpha-bungarotoxin sites in chromaffin cells in culture.
    Quik M; Afar R; Geertsen S; Audhya T; Goldstein G; Trifaró JM
    Mol Pharmacol; 1990 Jan; 37(1):90-7. PubMed ID: 1967819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymopoietin inhibits function and ligand binding to nicotinic receptors at the neuromuscular junction.
    Quik M; Collier B; Audhya T; Goldstein G
    J Pharmacol Exp Ther; 1990 Sep; 254(3):1113-9. PubMed ID: 1967127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymopoietin, a thymic polypeptide, specifically interacts at neuronal nicotinic alpha-bungarotoxin receptors.
    Quik M; Afar R; Audhya T; Goldstein G
    J Neurochem; 1989 Oct; 53(4):1320-3. PubMed ID: 2769271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for thymopoietin and thymopoietin/alpha-bungarotoxin/nicotinic receptors within the brain.
    Quik M; Babu U; Audhya T; Goldstein G
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2603-7. PubMed ID: 1848710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymopoietin, a polypeptide ligand for the alpha-bungarotoxin binding site in brain: an autoradiographic study.
    Afar R; Clarke PB; Goldstein G; Quik M
    Neuroscience; 1992; 48(3):641-53. PubMed ID: 1603334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymopoietin, a thymic polypeptide, potently interacts at muscle and neuronal nicotinic alpha-bungarotoxin receptors.
    Quik M
    Mol Neurobiol; 1992; 6(1):19-40. PubMed ID: 1463587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of the thymic polypeptide hormone thymopoietin with neuronal nicotinic alpha-bungarotoxin binding sites and with muscle-type, but not ganglia-type, nicotinic acetylcholine receptor ligand-gated ion channels.
    Lukas RJ; Audhya T; Goldstein G; Lucero L
    Mol Pharmacol; 1990 Dec; 38(6):887-94. PubMed ID: 1701215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional nicotinic receptor expression in mesodermal cells transfected with MyoD cDNA.
    Quik M; Odeh R; Philie J; Szyf M
    Neuroscience; 1993 Dec; 57(3):787-95. PubMed ID: 8309537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinic receptor-elicited sodium flux in rat pheochromocytoma PC12 cells: effects of agonists, antagonists, and noncompetitive blockers.
    Daly JW; Nishizawa Y; Edwards MW; Waters JA; Aronstam RS
    Neurochem Res; 1991 Apr; 16(4):489-500. PubMed ID: 1922660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of synthetic thymopoietin on binding of alpha-bungarotoxin to rat neural membranes.
    Jennings KR; Shieh HM
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1993 Mar; 104(3):411-3. PubMed ID: 8103433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phorbol esters and d-tubocurarine up-regulate alpha-bungarotoxin sites in chromaffin cells in culture via distinct mechanisms.
    Geertsen S; Afar R; Trifaró JM; Quik M
    Neuroscience; 1990; 34(2):441-50. PubMed ID: 2159130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arg-Lys-Asp-Val-Tyr (thymopentin) accelerates the cholinergic-induced inactivation (desensitization) of reconstituted nicotinic receptor.
    Ochoa EL; Medrano S; de Carlin MC; Dilonardo AM
    Cell Mol Neurobiol; 1988 Sep; 8(3):325-31. PubMed ID: 3066488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of alpha-bungarotoxin sites in chromaffin cells in culture by nicotinic receptor ligands, K+, and cAMP.
    Geertsen S; Afar R; Trifaró JM; Quik M
    Mol Pharmacol; 1988 Oct; 34(4):549-56. PubMed ID: 2459593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic agonist-induced down regulation of neuronal alpha-bungarotoxin receptors.
    Messing A
    Brain Res; 1982 Jan; 232(2):479-84. PubMed ID: 7188033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of thymopoietin to the acetylcholine receptor.
    Venkatasubramanian K; Audhya T; Goldstein G
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3171-4. PubMed ID: 3458173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for the nicotinic alpha-bungarotoxin receptor in neurite outgrowth in PC12 cells.
    Chan J; Quik M
    Neuroscience; 1993 Sep; 56(2):441-51. PubMed ID: 8247271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effects of a thymic peptide, thymopoietin and myasthenic patient sera in rat myotube culture.
    Eymard B; Aimé C; Cottin C; Morel E; Goldstein G; Bach JF; Berrih-Aknin S
    J Neurol Sci; 1992 Oct; 112(1-2):216-22. PubMed ID: 1343090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.